BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 32292498)

  • 21. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
    Tang Y; Lv XL; Bao YZ; Wang JR
    Climacteric; 2021 Jun; 24(3):253-260. PubMed ID: 33084419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isobavachalcone inhibits RANKL-induced osteoclastogenesis via miR-193-3p/NF-κB/NFATc1 signaling pathway in BMMs cells.
    Liu X; Xu X; Li J; Shi L; Zeng Y; Tang S; Liu W; Jia L; Li Y; Zhang J
    Biosci Biotechnol Biochem; 2023 Aug; 87(9):960-971. PubMed ID: 37291698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
    Qian Z; Zhong Z; Ni S; Li D; Zhang F; Zhou Y; Kang Z; Qian J; Yu B
    J Cell Mol Med; 2020 Sep; 24(17):10112-10127. PubMed ID: 32790170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
    Sun P; Yang Q; Wang Y; Peng J; Zhao K; Jia Y; Zhang T; Lu X; Han W; Qian Y
    Drug Des Devel Ther; 2020; 14():4189-4203. PubMed ID: 33116407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
    Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
    Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
    Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
    Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption.
    Li S; Teguh D; Wu D; Liu L; Hu C; Yuan J; Inderjeeth CA; Xu J
    J Cell Physiol; 2023 Aug; 238(8):1823-1835. PubMed ID: 37334837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
    Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
    Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
    J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
    Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.
    Xiao L; Zhong M; Huang Y; Zhu J; Tang W; Li D; Shi J; Lu A; Yang H; Geng D; Li H; Wang Z
    Aging (Albany NY); 2020 Nov; 12(21):21706-21729. PubMed ID: 33176281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
    Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
    Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
    Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
    Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.